Breaking Down the FDA Guidance on Animal Drug Compounding

Unclear about the U.S. Food and Drug Administration (FDA) final guidance on animal drug compounding from bulk drug substances? Learn what the guidance means for you, your patients and the drugs you keep on your clinic’s shelves. Our panel of experts will review drug compounding while breaking down what is and what is not impacted by the FDA guidance for all animal species. Learn what the American Veterinary Medical Association is doing to ensure the veterinary profession’s compounding needs are met today and into the future. If you have a specific question you would like answered during this live webinar, please email wvma@wvma.org, using the subject line “Drug Compounding Question.”

Speakers

Gail C. Golab, PhD, DVM, MANZCVS, DACAW
Dr. Golab is Associate Executive Vice President and Chief Veterinary Officer for the American Veterinary Medical Association (AVMA), overseeing the association’s Animal and Public Health, Animal Welfare and Global Outreach Divisions. Previously, Dr. Golab has served as Chief Advocacy and Public Policy Officer, as Director of the Animal Welfare Division, and in a variety of other roles in the AVMA’s Publications, Education and Research, and Communications Divisions. Before her tenure at the AVMA, she spent several years in private companion animal practice, and prior to that served as Biochemical/Biomedical Research Consultant at the National Center for Supercomputing Applications at the University of Illinois. Dr. Golab graduated with a PhD from Texas A&M University, a DVM from the University of Illinois, is certified as a member of the Australian and New Zealand College of Veterinary Scientists (Animal Welfare), is a charter diplomate of the American College of Animal Welfare (an AVMA-recognized veterinary specialty board) and a Distinguished Fellow in the National Academies of Practice.

Mike Murphy, DVM, JD, PhD
Dr. Mike Murphy is the American Veterinary Medical Association (AVMA) Director of the Division of Animal and Public Health, a position he has held since September 2019. Prior to joining the AVMA, Dr. Murphy spent 10 years at the U.S. Food and Drug Administration’s Center for Veterinary Medicine, and 22 years on faculty at the University of Minnesota and staff in the Minnesota Veterinary Diagnostic Laboratory. Dr. Murphy holds Professor Emeritus status from the University of Minnesota. After graduating from Texas A&M University’s (TAMU) College of Veterinary Medicine, he practiced in mixed animal clinics in northeastern Oklahoma before returning to TAMU and the Texas Veterinary Medical Diagnostic Laboratory to pursue graduate studies.

Dharati Szymanski DVM, MPH
Dr. Szymanski is the American Veterinary Medical Association (AVMA) Assistant Director of the Division of Animal and Public Health. She serves as the staff consultant to the Council on Biologic and Therapeutic Agents, the Clinical Practitioners Advisory Committee, the Council on Public Health and the Food Safety Advisory Committee. Prior to her position at AVMA, Dr. Szymanski served as a shelter veterinarian in the Chicago area and before that, spent several years in companion animal private practice in the Chicago and Washington, D.C., areas.